Evelo Biosciences, Inc (EVLO)

Etorro trading 970x250
Evelo Biosciences, Inc (EVLO) Logo

About Evelo Biosciences, Inc

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in clinical development trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also engages in developing EDP1867, an inactivated investigational oral biologic for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Address: 620 Memorial Drive, Cambridge, MA, United States, 02139

Evelo Biosciences, Inc News and around…

Latest news about Evelo Biosciences, Inc (EVLO) common stock and company :

How Many Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares Do Institutions Own?
18 Oct, 2021 Yahoo! Finance

A look at the shareholders of Evelo Biosciences, Inc. ( NASDAQ:EVLO ) can tell us which group is most powerful. Large...

44 Biggest Movers From Yesterday
15 Oct, 2021 FinancialContent

Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. ...

Wall Street Analysts Believe Evelo Biosciences, Inc. (EVLO) Could Rally 164%: Here's is How to Trade
13 Oct, 2021 Yahoo! Finance

The consensus price target hints at a 164.5% upside potential for Evelo Biosciences, Inc. (EVLO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change
13 Oct, 2021 Yahoo! Finance

Invaio Sciences, Inc., a Flagship Pioneering company unlocking the potential of natural systems to accelerate the transition to sustainable agriculture to urgently address climate change, has entered into a $50 million loan and security agreement with K2 HealthVentures (K2HV), a healthcare and life sciences-focused investment firm.

Evelo Biosciences Presents Preclinical Data for EDP1867 at 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
13 Oct, 2021 Yahoo! Finance

–Data suggest SINTAX™ medicine may overcome blood-brain barrier limitations to anti-inflammatory drug delivery– –EDP1867 reduced disease severity and incidence of relapse in murine model of multiple sclerosis– –Data support development of EDP1867 for the treatment of neuroinflammatory diseases– CAMBRIDGE, Mass., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing SINTAX medicines as a new modality of orally delivered treatmen

48 Biggest Movers From Yesterday
29 Sep, 2021 FinancialContent

Gainers Gogo Inc. (NASDAQ: GOGO) shares climbed 37.6% to close at $16.82 on Tuesday after the company raised the long-term ...

12 Health Care Stocks Moving In Tuesday's Intraday Session
28 Sep, 2021 FinancialContent

Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 35.02% to $7.22 during Tuesday's regular session. ...

36 Stocks Moving In Tuesday's Mid-Day Session
28 Sep, 2021 FinancialContent

Gainers Digital Brands Group, Inc. (NASDAQ: DBGI) shares climbed 39.3% to $4.1090 after the company issued full-year 2022 revenue ...

Evelo (EVLO) Posts Positive Data from Phase II Psoriasis Study
28 Sep, 2021 Yahoo! Finance

Evelo Biosciences (EVLO) reports encouraging data from a phase II study evaluating EDP1815 for the treatment of mild and moderate psoriasis. Shares up in pre-market trading.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
28 Sep, 2021 FinancialContent

Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 70.28% to $9.11 during Tuesday's pre-market ...

Noteworthy Monday Option Activity: KRA, EVLO, PRTY
27 Sep, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Kraton Corp (KRA), where a total of 4,914 contracts have traded so far, representing approximately 491,400 underlying shares. That amounts to about 186.8% of KRA's average daily trading volume over the past month of 263,035 shares..

Mid-Day Market Update: Crude Oil Rises 2%; ASLAN Pharmaceuticals Shares Slide
27 Sep, 2021 FinancialContent

Midway through trading Monday, the Dow traded up 0.70% to 35,041.74 while the NASDAQ fell 0.51% to 14,970.85. The S&P also rose, ...

31 Stocks Moving In Monday's Mid-Day Session
27 Sep, 2021 FinancialContent

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, ...

Mid-Morning Market Update: Markets Mixed; US Durable Goods Orders Increase Sharply In August
27 Sep, 2021 FinancialContent

Following the market opening Monday, the Dow traded up 0.65% to 35,024.73 while the NASDAQ fell 0.98% to 14,899.77. The S&P also ...

Evelo Biosciences Psoriasis Candidate Shows Benefit In Mid-Stage Study
27 Sep, 2021 FinancialContent

Evelo Biosciences Inc(NASDAQ: EVLO) hasannounced data from its Phase 2 studyof EDP1815 for mild and moderate ...

Evelo Biosciences Announces Positive Phase 2 Clinical Data with EDP1815 in Psoriasis; Confirms Ability to Harness the Small Intestinal Axis, SINTAX™, to Treat Systemic Inflammatory Disease
27 Sep, 2021 FinancialContent
Evelo Biosciences to Present at 2021 Cantor Global Healthcare Conference
20 Sep, 2021 FinancialContent
48 Biggest Movers From Friday
20 Sep, 2021 FinancialContent

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded ...

Notable Friday Option Activity: EVLO, FCX, CVGW
17 Sep, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Evelo Biosciences Inc (EVLO), where a total of 1,635 contracts have traded so far, representing approximately 163,500 underlying shares. That amounts to about 78.2% of EVLO's average daily trading volume over the past month of 209,100 shares..

Evelo Biosciences Enters Oversold Territory (EVLO)
14 Sep, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

How The Parts Add Up: VHT Targets $287
10 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Health Care ETF (VHT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $286.99 per unit.

Evelo Biosciences Announces Issuance of U.S. Patent for Pharmaceutical Compositions of Single Strains of Naturally Occurring Bacteria as Medicines
09 Sep, 2021 FinancialContent

Patent covers formulations of Veillonella parvula bacteria, including EDP1867, which is in Phase 1b clinical trial with interim data expected in 4Q 2021

Implied Volatility Surging for Evelo Biosciences (EVLO) Stock Options
08 Sep, 2021 Yahoo! Finance

Investors need to pay close attention to Evelo Biosciences (EVLO) stock based on the movements in the options market lately.

Noteworthy Tuesday Option Activity: TW, EVLO, TGT
07 Sep, 2021 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Tradeweb Markets Inc (TW), where a total volume of 1,936 contracts has been traded thus far today, a contract volume which is representative of approximately 193,600 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 84.3% of TW's average daily trading volume over the past month, of 229,560 shares..

Evelo Biosciences Appoints Iain McInnes, M.B.Ch.B, Ph.D, to Board of Directors
07 Sep, 2021 FinancialContent
53 Biggest Movers From Friday
07 Sep, 2021 FinancialContent

Gainers Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock ...

12 Health Care Stocks Moving In Friday's Intraday Session
03 Sep, 2021 FinancialContent

Gainers Cellect Biotechnology (NASDAQ:APOP) stock increased by 29.9% to $7.14 during Friday's regular session. Trading volume for ...

35 Stocks Moving In Friday's Mid-Day Session
03 Sep, 2021 FinancialContent

Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 35% to $7.43. Cellect Biotechnology announced the first ApoGraft ...

Notable Tuesday Option Activity: TBPH, ERII, EVLO
24 Aug, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Theravance Biopharma, Inc. (TBPH), where a total of 4,600 contracts have traded so far, representing approximately 460,000 underlying shares..

Are Options Traders Betting on a Big Move in Evelo (EVLO) Stock?
06 Aug, 2021 Yahoo! Finance

Investors need to pay close attention to Evelo (EVLO) stock based on the movements in the options market lately.

Evelo Biosciences, Inc (EVLO) is a NASDAQ Common Stock listed in , ,

970x250